Search Results - "Zeldenrust, Stephen R."

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy by Dingli, David, Ailawadhi, Sikander, Bergsagel, P Leif, Buadi, Francis K, Dispenzieri, Angela, Fonseca, Rafael, Gertz, Morie A, Gonsalves, Wilson I, Hayman, Susan R, Kapoor, Prashant, Kourelis, Taxiarchis, Kumar, Shaji K, Kyle, Robert A, Lacy, Martha Q, Leung, Nelson, Lin, Yi, Lust, John A, Mikhael, Joseph R, Reeder, Craig B, Roy, Vivek, Russell, Stephen J, Sher, Taimur, Stewart, A Keith, Warsame, Rahma, Zeldenrust, Stephen R, Rajkumar, S Vincent, Chanan Khan, Asher A

“…Life expectancy in patients with multiple myeloma is increasing because of the availability of an increasing number of novel agents with various mechanisms of…”
Get full text

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement by Gonsalves, Wilson I., Buadi, Francis K., Ailawadhi, Sikander, Bergsagel, P. Leif, Chanan Khan, Asher A., Dingli, David, Dispenzieri, Angela, Fonseca, Rafael, Hayman, Susan R., Kapoor, Prashant, Kourelis, Taxiarchis V., Lacy, Martha Q., Larsen, Jeremy T., Muchtar, Eli, Reeder, Craig B., Sher, Taimur, Stewart, A. Keith, Warsame, Rahma, Go, Ronald S., Kyle, Robert A., Leung, Nelson, Lin, Yi, Lust, John A., Russell, Stephen J., Zeldenrust, Stephen R., Fonder, Amie L., Hwa, Yi L., Hobbs, Miriam A., Mayo, Angela A., Hogan, William J., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A., Roy, Vivek

“…Over the last two decades, the utilization of various novel therapies in the upfront or salvage settings has continued to improve survival outcomes for…”
Get full text

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis by Milani, Paolo, Dispenzieri, Angela, Scott, Christopher G, Gertz, Morie A, Perlini, Stefano, Mussinelli, Roberta, Lacy, Martha Q, Buadi, Francis K, Kumar, Shaji, Maurer, Mathew S, Merlini, Giampaolo, Hayman, Suzanne R, Leung, Nelson, Dingli, David, Klarich, Kyle W, Lust, John A, Lin, Yi, Kapoor, Prashant, Go, Ronald S, Pellikka, Patricia A, Hwa, Yi L, Zeldenrust, Stephen R, Kyle, Robert A, Rajkumar, S Vincent, Grogan, Martha

“…Heart involvement is the most important prognostic determinant in AL amyloidosis patients. Echocardiography is a cornerstone for the diagnosis and provides…”
Get full text

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias by Kourelis, Taxiarchis V., Kumar, Shaji K., Go, Ronald S., Kapoor, Prashant, Kyle, Robert A., Buadi, Francis K., Gertz, Morie A., Lacy, Martha Q., Hayman, Suzanne R., Leung, Nelson, Dingli, David, Lust, John A., Lin, Yi, Zeldenrust, Stephen R., Rajkumar, S. Vincent, Dispenzieri, Angela

“…AL amyloidosis (AL) is rare and frequently remains undiagnosed until organ function is compromised, even among patients with known pre‐existing untreated…”
Get full text

Prognostic model for disease‐specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia by Ghobrial, Irene M., Fonseca, Rafael, Gertz, Morie A., Plevak, Matthew F., Larson, Dirk R., Therneau, Terry M., Wolf, Robert C., Hoffmann, Randi J., Lust, John A., Witzig, Thomas E., Lacy, Martha Q., Dispenzieri, Angela, Vincent Rajkumar, S., Zeldenrust, Stephen R., Greipp, Philip R., Kyle, Robert A.

“…Summary We sought to define prognostic factors for survival in Waldenstrom macroglobulinaemia (WM). Of 585 patients diagnosed with WM and seen at Mayo Clinic…”
Get full text

Therapy for Relapsed Multiple Myeloma by Dingli, David, MD, PhD, Ailawadhi, Sikander, MD, Bergsagel, P. Leif, MD, Buadi, Francis K., MD, Dispenzieri, Angela, MD, Fonseca, Rafael, MD, Gertz, Morie A., MD, Gonsalves, Wilson I., MD, Hayman, Susan R., MD, Kapoor, Prashant, MD, Kourelis, Taxiarchis, MD, Kumar, Shaji K., MD, Kyle, Robert A., MD, Lacy, Martha Q., MD, Leung, Nelson, MD, Lin, Yi, MD, PhD, Lust, John A., MD, PhD, Mikhael, Joseph R., MD, Reeder, Craig B., MD, Roy, Vivek, MD, Russell, Stephen J., MD, PhD, Sher, Taimur, MD, Stewart, A. Keith, MBChB, Warsame, Rahma, MD, Zeldenrust, Stephen R., MD, PhD, Rajkumar, S. Vincent, MD, Chanan Khan, Asher A., MD

“…Abstract Life expectancy in patients with multiple myeloma is increasing because of the availability of an increasing number of novel agents with various…”
Get full text

A novel report of cig‐FISH and cytogenetics in POEMS syndrome by Bryce, Alan H., Ketterling, Rhett P., Gertz, Morie A., Lacy, Martha, Knudson, Ryan A., Kumar, Shaji, Kyle, Robert A., Fonseca, Rafael, Greipp, Phillip R., Lust, John A., Rajkumar, Vincent S., Hayman, Suzanne R., Buadi, Francis, Russell, Stephen J., Zeldenrust, Stephen R., Dispenzieri, Angela

“…POEMS syndrome is a plasma cell proliferative disorder whose pathogenesis is poorly understood. We provide the first report of cytoplasmic immunoglobulin/FISH…”
Get full text

A novel report of clg-FISH and cytogenetics in POEMS syndrome by BRYCE, Alan H, KETTERLING, Rhett P, RAJKUMAR, Vincent S, HAYMAN, Suzanne R, BUADI, Francis, RUSSELL, Stephen J, ZELDENRUST, Stephen R, DISPENZIERI, Angela, GERTZ, Morie A, LACY, Martha, KNUDSON, Ryan A, KUMAR, Shaji, KYLE, Robert A, FONSECA, Rafael, GREIPP, Phillip R, LUST, John A

Get full text

Independent prognostic value of stroke volume index in patients with light-chain amyloidosis by Milani, Paolo, Dispenzieri, Angela, Scott, Christopher G., Gertz, Morie A., Perlini, Stefano, Mussinelli, Roberta, Lacy, Martha Q., Buadi, Francis K., Kumar, Shaji, Maurer, Mathew S., Merlini, Giampaolo, Hayman, Suzanne R., Leung, Nelson, Dingli, David, Klarich, Kyle W., Lust, John A., Lin, Yi, Kapoor, Prashant, Go, Ronald S., Pellikka, Patricia A, Hwa, Yi L., Zeldenrust, Stephen R., Kyle, Robert A., Rajkumar, S. Vincent, Grogan, Martha

Get full text

Immunoglobulin Light Chain Gene Constant Region Is An Invariable Part of Amyloid Deposits in AL Amyloidosis by Theis, Jason D., Vrana, Julie A., Gamez, Jeffrey D., Dispenzieri, Angela, Zeldenrust, Stephen R., Dogan, Ahmet

“…Background: Amyloidosis caused by immunoglobulin light chain (IGLC) deposition, so-called AL-type or primary amyloidosis, is the most common type of…”
Get full text

Long Term Follow-up of Patients with Immunoglobulin Light Chain Amyloidosis Treated with Lenalidomide and Dexamethasone by Dispenzieri, Angela, Lacy, Martha, Zeldenrust, Stephen R., Hayman, Suzanne R., Kumar, Shaji K., Lust, John A., Allred, Jake, Rajkumar, S. Vincent, Greipp, Philip R., Laumann, Kristina, Russell, Stephen, Buadi, Francis, Witzig, Thomas E, Gertz, Morie A

“…Background: Primary systemic amyloidosis (AL) is an incurable plasma cell disorder. Lenalidomide, especially in conjunction with dexamethasone, has been shown…”
Get full text

Pomalidomide (CC4047) Plus Low-Dose Dexamethasone (Pom/dex) Is Highly Effective Therapy in Relapsed Multiple Myeloma by Lacy, Martha Q., Hayman, Suzanne R., Gertz, Morie A., Allred, Jacob B., Mandrekar, Sumithra J., Dispenzieri, Angela, Zeldenrust, Stephen R., Kumar, Shaji, Greipp, Philip R., Lust, John A., Russell, Stephen J, Buadi, Francis, Kyle, Robert A., Bergsagel, Peter Leif, Fonseca, Rafael, Roy, Vivek, Mikhael, Joseph, Stewart, A. Keith, Rajkumar, S. Vincent

“…Background: Thalidomide and its analogue lenalidomide have high response rates among patients with newly diagnosed as well as previously treated myeloma…”
Get full text

Pomalidomide (CC4047) plus Low-Dose Dexamethasone (Pom/Dex) as Therapy for Relapsed Multiple Myeloma by Lacy, Martha Q., Hayman, Suzanne R., Gertz, Morie A., Dispenzieri, Angela, Zeldenrust, Stephen R., Kumar, Shaji, Greipp, Philip R., Lust, John A., Russell, Stephen J., Buadi, Francis, Kyle, Robert A., Fonseca, Rafael, Bergsagel, P. Leif, Roy, Vivek, Mikhael, Joseph R., Stewart, A. Keith, Allred, Jacob B., Laumann, Kristina, Thompson, Melanie, Mandrekar, Sumithra J., Rajkumar, S. Vincent, Dingli, David, Reeder, Craig

Get full text